Skip to content

Rama Dahal, M.D.

NPI 1407918550ActiveIndividual· Internal Medicine· Manahawkin, NJ

Internal Medicine (M.D.) in Manahawkin, New Jersey, licensed in NJ and PA, with an NPI issued in December 2006. Part D covered 898 prescriptions written in 2024, 90% of them generic. Glaxosmithkline, LLC. reported $17.97 in payments in 2025, mostly food and beverage.

Overview

NPI1407918550
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedDec 15, 2006
Last updated in NPPESFeb 11, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X25MA08195000NJ
Internal Medicine207R00000XMD430423PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (PA)

Part D prescriptions in 2024

Prescriptions (claims)898 · 1,787 30-day fills
Patients179
Total drug cost$54,682
Generic share90% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$17.97 · 1 payment from 1 company
  • 2024$36.04 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$17.971

What the 2025 payments were for

  • Food and Beverage$17.97 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Manahawkin

All Internal Medicine providers in New Jersey →